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                                             INTRODUCTION 
Diabetes mellitus (DM) is group of metabolic disorders that share the common 
phenotype of hyperglycemia caused by complex interaction of genetic and 
environmental factors and life style choices. Hyperglycemia can occur due to 
decreased insulin secretion, decreased glucose utilization and increased glucose 
production. The metabolic dysregulation associated with DM causes secondary 
pathophysiological changes in multiple organ systems. It’s a leading cause of 
end stage renal disease, nontraumatic lower limb amputation and adult 
blindness. 
  DM is classified according to the pathogenic process that leads to 
hyperglycemia into two broad categories type 1 and type 2. In type 1 DM there 
is autoimmune destruction of beta cells in pancreas leading to insulin 
deficiency. Type 2 is characterized by varying degrees of insulin resistance, 
decrease in insulin production and increase in glucose production. Type 1 
usually develops before the age of 30 years while type 2 develops with 
increasing age. (But 5-10% of cases diagnosed after 30 years of age have 
immune destruction of beta cells and type 2 can also occur in children especially 
obese adolescents). Approximately 10% of diabetic population has type 1 DM 
and majority belong to type 2.           
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 Chronic complications of DM affect many organ systems. These can be 
classified as vascular and nonvascular complications. Vascular complications 
can be further classified as microvascular and macrovascular. 
Microvascular complications:  
a. Diabetic retinopathy 
b. Nephropathy 
c. Neuropathy: Sensory, motor, autonomic. 
Macrovascular complications: 
a. Coronary artery disease 
b. Peripheral vascular disease 
c. Cerebrovascular disease 
Nonvascular complications: 
a. Gastrointestinal: Gastrointestinal paresis, diarrhea 
b. Genitourinary: Uropathy, sexual dysfunction 
c. Dermatological 
d. Infectious 
e. Cataract 
f. Glaucoma. 
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Microvascular complications are caused due to hyperglycemia and it is 
conclusively proven that if hyperglycemia is well controlled, these 
complications can be prevented or delayed. 
 Type 2 DM has a long asymptomatic period, so it can present with these 
complications.          
 Diabetic retinopathy (DR) is a highly specific vascular complication of 
both type 1 and type 2 diabetes mellitus.. After 20 years of diabetes, nearly all 
patients with type 1 diabetes and more than 60% of patients with type 2 diabetes 
have some degree of retinopathy. 
   
 DR goes through various stages before leading to visual loss. The first 
clinical signs are microaneurysms. Then slowly it progresses and leads to 
formation of new vessels in retina which can lead to sight threatening 
complications like vitreous haemorrhage. 
 In general, the progression of retinopathy is orderly, advancing from mild 
nonproliferative abnormalities, characterized by increased vascular 
permeability, to moderate and severe nonproliferative diabetic retinopathy 
(NPDR), characterized by vascular closure, to proliferative diabetic retinopathy 
(PDR), characterized by the growth of new blood vessels on the retina and 
posterior surface of the vitreous.  The severity and progression of diabetic 
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retinopathy is affected by many factors. Duration of diabetes, glycosylated 
haemoglobin, type of treatment (insulin treatment versus non-insulin treatment), 
systolic and diastolic blood pressures and serum creatinine, showed a positive 
association with retinopathy while body mass index (BMI) showed an inverse 
association. 
                                          REVIEW OF LITERATURE 
Diabetic retinopathy is a microvascular complication of both type 1 & 
type 2 diabetes mellitus. In the eye its effects are seen predominantly in the 
retina. It causes loss of  vision due to intraocular hemorrhage, tractional retinal 
detachment, clinically significant macular edema, and macular ischaemia. 
According to one study, yearly incidence of sight-threatening diabetic 
retinopathy in patients without retinopathy at baseline was 0.3% in the first 
year, rising to 1.8% in the fifth year, cumulative incidence at 5 years was 3.9%. 
Whereas for background diabetic retinopathy, rates of progression to sight-
threatening diabetic retinopathy in 1 year was 5% and for preproliferative 
diabetic retinopathy was 15%. Diabetic retinopathy causes damage by formation 
of advanced glycosylation end products, increased metabolism via sorbitol 
pathway and more importantly increased metabolism via hexosamine pathway 
leading to increased production of various growth factors like vascular 
endothelial growth factor (VEGF).  
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      According to 2004 WHO publication  there are 171 million people 
worldwide who have diabetes mellitus and the figures are likely double by 
2030. India has about 31.7 million diabetic patients ranking first in the world. 
This number is projected to increase to 79.4 million by 2030. 
 In the Chennai Urban Rural Epidemiology Study (CURES) eye study I, 
the prevalence of diabetic retinopathy was found to be 17.6%. Another similar 
study CURES-2 was done to study the association of serum lipids with 
diabetic retinopathy in urban South Indians—the Chennai Urban Rural 
Epidemiology Study (CURES) Eye Study—2. 
In general, the progression of retinopathy is orderly, advancing from mild 
nonproliferative abnormalities, characterized by increased vascular 
permeability, to moderate and severe nonproliferative diabetic retinopathy 
(NPDR), characterized by vascular closure, to proliferative diabetic retinopathy 
(PDR), characterized by the growth of new blood vessels on the retina and 
posterior surface of the vitreous. These new vessels may cause intraocular 
bleeding or the gliosis associated with them may cause tractional retinal 
detachment leading to significant visual loss.  
The Early Treatment Diabetic Retinopathy Study (ETDRS) classification  
given by the ETDRS group was a modified Airlie House classification of 
diabetic retinopathy which was also used in the Diabetic Retinopathy study 
(DRS). The seven standard photographic fields were used, and the original 
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standard colour nonsimultaneous stereoscopic photographs were retained. New 
photographs were added and some additional characteristics were described.  
The classification was more elaborative and was more standardized which 
allowed a very little chance of examiner bias. Thus it has gained worldwide 
acceptance and presently is a standard for classification of diabetic retinopathy. 
ETDRS was a multicentric, randomized clinical trial basically designed to 
evaluate argon laser photocoagulation and aspirin treatment in the management 
of patients with nonproliferative or early proliferative diabetic retinopathy.  
ETDRS classified diabetic retinopathy into mild, moderate, severe, very severe, 
early PDR and high risk PDR depending on the characteristic lesions seen.    
            DIABETIC RETINOPATHY PRVALENCE AND INCIDENCE 
Nearly 171 million people worldwide have diabetes. This figure is likely to 
double by 2030. India holds 31.7 million diabetic patients ranking first in the 
world. This number is projected to increase to 79.4 million by 2030. 
In 2002 DR accounted for about 5% of world blindness amounting to almost 5 
million blind.  In India, prevalence of DR has been reported to range from 
10.5% to 26.2%.   It remains a leading cause of new blindness in developed and 
developing countries between the ages of 20 and 74 years. The increasing 
incidence of diabetes has caused DR to be included in the “priority list” as a part 
of “Vision 2020”.  
 13
Worldwide Diabetic retinopathy accounts for 5% of total blindness. In the 
Chennai Urban Rural Epidemiology Study (CURES) eye study I, the prevalence 
of diabetic retinopathy was found to be 17.6%. A 1996 report from Madurai 
revealed that of the 1863 new diabetic patients seen at a tertiary centre, 37% had 
overt diabetic retinopathy14. The increasing incidence of  diabetes has caused 
diabetic retinopathy to be included in the priority list as part of vision 2020.           
 
                SYSTEMIC FACTORS ASSOCIATED WITH DIABETIC RETINOPATHY 
1. One of these is puberty, whether because of the marked hormonal changes that 
occur at this time or for other reasons. 
2. Elevated levels of IGFs may enhance the development of of proliferative 
diabetic retinopathy ,in particular the rapidly progressive , or “florid”, 
retinopathy that is occasionally seen in young people late in adolescent or in 
young adulthood. 
3. Growth hormone and IGF-1 are probably permissive for the development of 
retinal neovascularization but are not directly causal. 
4. Increased blood pressure and increased blood sugar levels increase the risk for 
the development and progression of diabetic retinopathy. 
5. Unilateral narrowing of the internal carotid artery resulting from 
arteriosclerosis protected the ipsilateral eye from developing diabetic 
retinopathy. 
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                       PATHOLOGY  OF  DIABETIC RETINOPATHY  
 
Various mechanisms put forth for the pathogenesis of hyperglycemia induced 
damage are:    
1. Formation of advanced glycosylation end products 
2. Increased metabolism via sorbitol pathway 
3. Increased metabolism via hexosamine pathway leading to 
increased formation of fructose 6 phosphate which leads to 
increased production of various growth factors like vascular 
endothelial growth factors (VEGF) 
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SCHEMATIC DIAGRAM OF DIABETIC RETINOPATHY PATHOGENESIS 
Hyperglycemia                    Fibrinolytic activity        Increased platelet aggregation 
Increased growth hormone                                         Increased RBC deformability 
Increased hepatic protein synthesis                            Increased 2,3 DPG 
Fibrinogen                                                                   Increased Haemoglobin A C 
Alpha 1 , alpha 2 globulin 
Increased aggregation                                                 Increased RBC O2 affinity 
Increased retinal microinfarction 
 
                Retinal hypoxia 
                  Increased vasoformation factor 
                  Increased Neovascularisation 
                   NPDR                                                 PDR 
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So one can postulate the following sequence of events in the pathogenesis of 
diabetic retinopathy: 
a.   Hyperglyeaernia with insufficient insulin causes an increased output of 
growth hormone.  
b..  Elevated levels_of growth hormone in the presence of  reduced levels of 
insulin alter the hepatic cell synthesis of proteins causing a dvsproteinaemia.  
c.  Elevated levels of flbrinogen and alpha 2 globulin increase red cell 
aggregation.  
d.  Elcvated levels of growth hormone associated with increased production of 
Von Willebrand factor and reduced levels of prostacvclin increase platelet 
aggregation.  
e.  Hyperglycaemia impairs prostacyclin production by endothelial cells. 
lncreased RBC and platelet aggregation impair haemorheodynamics in  the 
microcirculation.  
g.  Impaired blood flow in the microcirculation by a sluggish flow rate or 
microinfarction leads to hypoxia and ischaemia.  
h.  Hypoxia and ischaemia probably cause diabetic retinopathy by the 
elaboration of a vasoformative factor which stimulates new vessels formation in 
the optic nerve region or the retina. Hypoxia and ischaemia can cause 
breakdown and leakage of retinal vessels,massively affect haemodvnamic  on 
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the nature.as well  as transudation and exudation of the blood elements into the 
retinal structures. 
PATHOLOGY:  
The histological picture of the vessels resemble the arteriosclerotic hypertensive 
picture.Terminal arterioles reveal hyaline thickening,coiling and narrowing of 
the lumen.The basement membrane of the capillaries is thickened and there is 
disappearance of intramural pericytes and endothelial cells.Ghost capillaries 
may be seen in diabetic retina which are occluded,functionless and these vessels 
have only thin basement membrane and possess neither pericytes nor 
endothelial cells.Adjacent to these capillaries normal functionlcss capillaries 
may also lose there intramural pericytes and endothelial cells and may he 
potential sites for saccular aneurysm,Adjaecnt to the distended and tortuous 
vessels are seen which might have developed to produce collateral circulation. 
In the beginning their walls are thin but later on get occluded by hyaline 
material. The haemorrhages are mostly confined to outer plexiform layer and 
Henle’s fibre layer and exudates are formed by polymerization of the 
unsaturated fats. They are chemically CEROID-wax like material and are 
regarded as breakdown products of degenerated neuronal tissue. The soft 
exudates are also seen and result from capillary infarction.
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                                                                                                   ETDRS classification  of Diabetic Retinopathy  
 
 
Nonproliferative                                                                                                                                                       Proliferative 
 
A. Mild NPDR    B. Moderate NPDR                           C.  Severe NPDR                                  D. Very severe NPDR 
At least one            Cotton wool spots &                        Haemorrhages and microaneurysms              Any 2 or more of   C          
Microaneurysm      IRMA definitely present                  in all four quadrants                                                                    
                                                                                Venous beading in two or more quadrants                                 
                                                                                       IRMA in at least one quadrant 
 
 
                                                               E.Early PDR                           F. High risk PDR 
 
                Neovascularisation not meeting criteria in F                                   NVD > 1/3-1/2 disc area  
                                                                                                      NVD and vitreous or preretinal haemorrhage 
                                                                                                   NVE > ½ disc area and vitreous or preretinal haemorrhage 
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                                   ETDRS classification [1991] 
Diabetic retinopathy is broadly classified as NPDR & PDR. Diabetic 
macular edema can occur in NPDR as well as PDR.  
Mild NPDR-  is marked by atleast one retinal microaneurysm, but  
hemorrhages or microaneurysm or both are less than those in ETDRS standard 
photograph no. 2A. No other retinal lesions or abnormalities associated with 
diabetes is present. Those patients with mild NPDR have a 5% risk of 
progressing to PDR within 1 year and  a 15% risk of progression to high risk 
PDR within 5 years 
Moderate NPDR- is characterized by hemorrhage or microaneurysm 
greater than those pictures in ETDRS standard photograph no 2A. cotton wool 
spots, venous beeding, and IRMAs are definitely present to mild degree. The 
risk of progression to PDR within 1 year is 12-27% and the risk of progression 
to high risk PDR within 5 years is 33%.  
Severe NPDR- based on the severity of hemorrhage or microaneurysm, 
IRMAs, and venous beeding is characterized by any one of the following 
lesions: H/Ma greater than standard photograph no 2A in 4 quadrants OR 
venous beeding in 2 or more quadrants OR IRMAs greater than standard 
photograph no 8A in atleast 1 quadrant. Clinically severe NPDR is diagnosed by 
applying the 4-2-1 rule. Eyes with severe NPDR have a 52% risk of developing 
PDR within 1 year and 60% risk of developing high risk PDR within 5 years  
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Very severe NPDR-  have 2 or more lesions of severe NPDR but no 
frank neovascularisation. There is 75% risk of developing PDR within 1 year.  
 
PDR- Diabetic retinopathy marked by new vessel growth on optic disc 
(NVD) or elsewhere (NVE) on retina or by fibrous tissue proliferation is 
designated PDR. Eyes with early PDR have a 75% risk of  developing high risk 
PDR within 5 year period. 
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ETDRS also defined the various lesions seen in DR. the various lesions seen are  
DEFINITIONS 
Microaneurysms (MA)–  
 A red spot that is less than 1/12 the diameter of an average optic disc, or 
125µm in its longest dimension (approximately the width of an average major 
vein at the disc margin) and that has sharp margins in considered to be a 
microaneurysm. Any red spot equal to or greater than 125µm in its longest 
dimension is considered to be a hemorrhage unless features such as round 
shape, smooth margins, and a central light reflex suggest that it is probably a 
microaneurysm.  
 
Hemorrhages (H) and/ or microaneurysms (MA)‐  
All punctate, blot, or linear hemorrhages and all microaneurysms 
(whether the color of venous blood or paler, and with or without a recognizable 
wall) are included. Microaneurysms that appear as white dots with no blood 
visible in a central lumen are graded as hard exudates. Hemorrhages that are 
clearly preretinal are excluded. The grading is based on the area of retina 
covered by hemorrhages and/or microaneurysms, using standard photographs 
1,2A and 2B for comparison. 
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Hard exudates – 
Hard exudates are small white or yellowish-white deposits with sharp 
margins. Often they have a slightly waxy or glistering appearance. They are 
usually located in the outer layers of the retina, but may be more superficial, 
particularly when retinal thickening (edema) is present. Hard exudates may be 
arranged as individual dots, as confluent patches, or in partial or complete rings 
surrounding prominent microaneurysms or zones of retinal edema. The grading 
of hard exudates is based on the area of retina involved, using standard 
photographs 3,4 and 5 for comparison.  
 
Soft exudates –  
Soft exudates are localized superficial swellings in the nerve fiber layer. 
They are round or oval in shape, white, pale yellow-white, or grayish-white in 
color, and have ill-defined (feathery) edges, frequently with striations parallel to 
the nerve fibers. The grading is based on the area of retina involved, using 
standard photographs 8A and 5. 
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Intraretinal microvascular abnormalities (IRMA)‐  
Tortuous Intraretinal vascular segments, varying in caliber from barely 
visible to 31µm (approximately one fourth the width of a major vein at the disc 
margin) or occasionally larger, are the abnormalities considered in this category. 
Punctate microaneurysms in the retina and new vessels located on the surface of 
the retina are excluded. The grading is based on the area of the retina covered 
by IRMA, using standard photographs 8A and 8B. 
 
Venous abnormalities‐  
In the ETDRS, three abnormalities that were combined in the DRS 
grading protocol are assessed separately: (a) venous beading, (b) venous 
narrowing, and (c) venous loops and/or reduplication. Venous sheathing and 
perivenous exudates are graded as in the DRS. Diffuse increase in venous 
caliber is not graded, because it is considered too difficult to evaluate 
consistently. Abnormalities within one half disc diameter (DD) of the disc 
margin are ignored.  
Venous beading‐  
Localized increases in venous caliber, which sometimes resemble a string 
of beads and are typical of diabetic retinopathy, are the abnormalities assessed. 
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The grade is based on the total length of vein involved and the severity of 
beading, using standard photographs 6A and 6B for comparison.  
Venous narrowing‐  
Localized narrowing of venous caliber is the abnormality considered. The 
total length of all narrowed segments within the field being graded is estimated 
and compared with the width of an average major vein at the disc margin 
(considered to be 125µm) and the diameter of an average disc.  
Venous loops and/or reduplication‐ 
A venous loop is an abrupt, curving deviation of a vein from its normal 
path. Reduplication of a vein is the dilation of a pre-existing channel or the 
proliferation of a new channel of similar caliber adjacent to the original vein. 
The grading is based on the caliber of the vein involved.  
Venous sheathing‐  
White lines along one or both sides of the venous blood column 
(sheathing) and/or complete opacification of the venous wall (white threads) are 
the abnormalities graded. The total length of vein having either appearance is 
assessed, as with venous narrowing.  
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Perivenous exudates‐  
Hard exudates occurring immediately adjacent to one or both sides of 
retinal veins, simulating venous sheathing, are classified as perivenous exudates 
and graded separately.  The total length of vein involved is assessed.  
 
Arteriolar abnormalities‐  
Abnormalities within ½ DD of the disc margin are ignored 
Arteriolar narrowing- 
Localized irregularities in arteriolar caliber are the abnormalities graded. 
Because it is considered too difficult to grade consistently, generalized 
narrowing is not evaluated, except to indicate narrowing so extensive that the 
arterioles and white threads are excluded when grading arteriolar narrowing. 
The grading is based on the length of arteriolar segments involved, using 
standard photographs 11 and 7. 
Arteriolar sheathing‐  
Arteriolar walls that are partially opaque (a ribbon of red blood can still 
be seen with white lines on one or both sides of it) or completely opaque (no 
visible red blood column), are the abnormalities graded. The total length of 
arteriole that is either partially or fully opaque is assessed, using as cut points on 
the grading scale 125µm and standard photographs 5 and 7. 
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New vessels - 
New vessels that are clearly on the surface of the retina (that is, not 
within the retina) or further forward in the vitreous cavity are considered to be 
new vessels elsewhere (NVE), except for those on the disc or within 1 DD of its 
margin (or in the vitreous anterior to this area), which are designated new 
vessels of the disc (NVD). However, if new vessels located mostly elsewhere 
extend into the area between ½ and 1 DD from the disc margin, and no other 
new vessels are present closer to or on the disc, all new vessels are included in 
the NVE category. These same criteria are used to distinguish between fibrous 
proliferations elsewhere (FPE) and fibrous proliferations of the disc (FPD). The 
grading is based on the area of retina covered by the new vessels, using as cut 
points on the grading scale ½ disc area (DA) and the NVE in standard 
photograph 7. 
 
Preretinal hemorrhage‐  
Both boat-shaped hemorrhages with a fluid level and round, oval, or 
linear patches of the hemorrhage just anterior to the retina or under its internal 
limiting membrane are included. Hemorrhage on the surface of detached retina 
is also considered to be preretinal hemorrhage. The grading is based on the area 
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of retina covered by hemorrhage, using standard photographs 9 and 13 and the 
area of one half of the field for comparison.  
 
Vitreous hemorrhage‐ 
Hemorrhage further forward in the vitreous cavity than pre retinal 
hemorrhage(PRH), including hemorrhage on or within fibrovascular 
proliferations, is considered to be vitreous hemorrhage (VH) .  
 
 
The United Kingdom Prospective Diabetes study (UKPDS) was a 
landmark trial in NIDDM. It was a multicentric, randomised control trial. Both 
eyes of 2964 patients were studied. It concluded that increased blood pressure 
and increase fasting plasma glucose was associated with increased severity of 
retinopathy. Other conclusions derived were that retinopathy was more 
prevalent in men than women, body mass index (BMI) was inversely related to 
severity of retinopathy in women but not in men. High density lipoproteins 
(HDL) which has a protective role in atherosclerotic diseases was found to have 
inverse relationship with severity of retinopathy in men, i.e. higher HDL levels 
were associated with increased severity of retinopathy in men. But this was not 
so in women .   
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The Wisconsin Epidemiologic study of Diabetic Retinopathy which 
include 634 patient with IDDM also concluded that progression of retinopathy 
is more in males, in those having higher glycosylated hemoglobin and higher 
diastolic blood pressure at baseline .  
 
                BIO-CHEMICAL ASPECTS IN DIABETIC RETINOPATHY 
Diabetes occurs essentially in two forms: type 1, formerly known as juvenile-
onset diabetes (or type I); and type 2, which was once called mature-onset 
diabetes (or type II). Although the mechanisms for each vary, both forms 
involve an inability of glucose to enter certain classes of cells in the body that 
are dependent upon insulin-activated, transport protein systems. 
TYPE 1 DIABETES : Type 1 diabetes was formerly called “juvenile diabetes” 
since it typically becomes manifest by age 20. However, it is now known that 
this form can occur after that age. Type 1 was also known as “insulin dependent 
diabetes” since its patients require periodic insulin injections. Again ,however 
patients with type 2 diabetes sometimes also require insulin injections. The 
immediate cause of type 1 is usually an autoimmune destruction of the b-cells of 
the pancreas that synthesize insulin. In addition to its role in glucose uptake , 
insulin signals the initiation of many other cell metabolic functions : amino acid 
uptake , glycolysis, formation of glycogen , and lipid synthesis as well as the 
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synthesis of proteins , DNA, and RNA. One can say that insulin is vital 
hormone since it communicates the continuation of cell nutrition and growth 
overall. However, the uptake of glucose remains as one of its most important 
functions. 
  The destruction of  the b-cells of the pancreas , as mentioned above , appears 
to be an autoimmune phenomenon. There is a strong genetic component to the 
appearance of this form of diabetes, which is associated with the chromosome 6 
genes for the human leukocyte  antigens (HLA). Wildman and Medeiros(2000), 
describe these proteins , made by their respective genes, as critical for 
distinguishing between host and foreign cells. Because of the loss of insulin , 
high levels of glucose remain in the circulating blood long after the 
consumption of a meal. For this reason , type 1 diabetes has also been known as 
insulin dependent diabetes mellitus (IDDM). 
                 It is important to understand that those cells that depend on insulin 
(those that have  GLUT-4 transport proteins) become starved for nourishment 
while other cells , not dependent on insulin , become exposed to higher than 
normal cytoplasmic levels of glucose . This is to say that some cells have 
decreased nutrition while other cells are actually exposed to toxic levels of 
glucose. Cells that are particularly insulin dependent are muscle cells (cardiac, 
skeletal , and smooth) as well as adipose (fat ) cells (McGilvery, Goldstein, 
1983) and cells of blood vessel walls ( Koschinsky, 1988). Among the cells 
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which are not insulin dependent are liver cells , nerve cells, red blood cells , 
bone cells, and lens fiber cells of the eye. This is why the enzyme aldose 
reductase is activated within lens fiber cells of the eye. This is why the enzyme 
aldose reductase is activated within lens fiber cells in the diabetic state. 
        In diabetes, particularly type 1, the insulin dependent cells alter their 
metabolism in pathological (i.e., abnormal ) ways in order to compensate for 
their lack of glucose . In muscle cells, for example , it is common in the diabetic 
state to accelerate the breakdown of aminoacids in order to obtain acetyl CoA as 
a precursor for ATP production. This occurs at the expense of muscle proteins 
in the body. In muscle cells, for example, it is common in the diabetic state to 
accelerate the breakdown of aminoacids in order to release fatty acids back into 
the bloodstream. These fatty acids are taken up by the liver to produce acetyl 
CoA for the same purpose of synthesizing ATP. However, in this case , not only 
are the stores of lipid reduced , but there is also a production of  toxic 
intermediates from excessive fatty acid breakdown. These toxic intermediates 
are known as ketone bodies. Most ketone bodies (acetoacetate  and B- 
Hydroxybutyrate) are sufficiently acidic to lower blood pH to dangerously low 
levels. This could occur to the point at which the patient might become 
comatose and, if untreated, could expire due to complications such as severe 
dehydration , respiratory distress, cerebral edema, and thromboembolism. Of 
46 
 
course, this represents an extreme of untreated type 1 diabetes or, in some cases 
, where insulin therapy management is very difficult. 
  High circulating levels of glucose can also bind to proteins both extracellularly 
and intracellularly (in those cells that do not have GLUT-4 transport proteins). 
The binding of glucose to proteins is known as glycation. Glycation is a slow 
reaction that proceeds through many steps. It is important to note that the 
reaction is permanent, meaning that when glucose levels are lowered the 
binding of glucose to the protein does not dissociate. Rather the reaction 
continues and produces more complex forms that result in the denaturation of 
the protein in what is known as the Maillard reaction (Berman ,1991). Finally, 
it should be noted that glucose in high concentrations has been proposed to 
cause DNA damage (Morita et al, 1985) . However,Schleicher et al (2001) , 
have indicated that only 1x 10-5% of the guanine nucleotides of DNA would be 
expected to react with a glucose derivative in the diabetic state. This is a 
negligible amount. 
TYPE 2 DIABETES: In type 2 diabetes formerly known as noninsulin 
dependent diabetes mellitus(NIDDM), there is either an insufficient number of 
functional insulin receptors on the plasma membranes of insulin dependent cells 
or the receptors, in normal amounts, fail to promote sufficient glucose uptake 
(Mathews, van Holde , 1990; Martin et al, 1985). The phenomenon of 
insufficient response to normal amounts of insulin is called insulin resistance. 
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In addition, patients with this disease also exhibit a somewhat decreased levelof 
secreted nsuln for unknown reasons. This insulin deficiency , however , does 
not often require insulin therapy. The cause(s) of type 2 diabetes remain vague ( 
Wildman, Medeiros, 2000). 
One causative attribute has been the association of this disease with obesity. 
How this occurs is not certain, but some evidence is available. For example , 
enlarged adipocytes (fat cells ) secrete a protein known as tumour necrosis 
factor-alpha that has been shown to inhibit insulin receptor 
autophosphorylation. 
         A characteristic of type 2 diabetes is that the associated hyperglycemia 
tends to develop more slowly than with type 1 and is of a milder degree. 
Ketoacidosis , in untreated type 2 diabetics, occurs much less often and then it is 
usually associated with physiological stress such as an infection. Returning to 
the problem of insulin resistance , one may point to not only the insulin receptor 
protein, but also to any of the proteins associated with the cascade from the 
receptor to the placement of GLUT-4 molecules at the the cell plasma 
membrane (Pessin, Saltiel,2000). This means that any number of proteins may 
contribute to the resistance. Numerous data support this to indicate many 
possible causes of the disease and emphasizes the difficulties of trying to 
comprehend how this disease can manifest itself. In addition to the effect of fat 
cells on the insulin receptor, investigations have shown that knocking out the 
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gene for the insulin substrate proteins (insulin receptor substrates) in mice can 
produce insulin resistance as well as cause a decreased b-cell production of 
insulin in the pancreas(Kulkarni et al , 1999). The next protein in the cascade is 
phosphatidylinositol 3-kinase (PI3-K). Although PI3-K activity id necessary for 
the ultimate transport of  GLUT-4 to the plasma membranes of  insulin 
dependent cells (Chez, Corvera,1999) , its activity is not sufficient to carry out 
the transport. This means that additional mechanisms are involved(Pessin, 
Saltiel,2000) and, clearly , more work will be necessary to unravel the causes of 
insulin resistance. In spite of these uncertainties , a controlled diet coupled with 
exercise is often sufficient to manage type 2 diabetes. 
The Diabetic Retina:  The retina is vulnerable to diabetes due to deterioration 
that occurs to its blood vessels in a condition known as diabetic retinopathy. 
This is similar to diabetic blood vessel damage that also occurs to other parts of  
the body such as the kidneys , brain , and limbs. Essentially , in the retina 
pericytes are destroyed while the lumen of the vessel becomes blocked due to 
vessel swelling as the basement membranes thicken (Apple et al, 1988). As 
vessel pathology develops, haemorrhages and retinal detachment follow. The 
terminal result of these events is loss of vision in parts or all of the retina. 
Shedding light on a biochemical mechanism by which this damage occurs has 
proven to be a Pandora’s box. As the box is opened, out pops the familiar 
enzyme aldose reductase and its role of removing excessively toxic amounts of 
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glucose from within cells such as blood vessel endothelial cells. Again, the 
problem of the generation of osmotic sorbitol arises. The problem ( the presence 
of  large amounts of high osmotic, cell destroying sorbital) and the solution 
(development of an effective inhibitor for aldose reductase ) are seen as logical 
exercise. However , other previously unknown participants emerge from the 
Pandora’s box: protein kinase C (PKC); mitogen-activated protein kinase 
(MAPK); protein glycation; and oxidative stress (Tomlinson, 2000). The 
complications to understanding that are generated by these other substances 
mechanisms are, nonetheless, now seen as more important in the retina 
compared to the lens osmotic hypothesis. This is so since aldose reductase 
inhibitors do not seem to have any significant effect on the prevention of  blood 
vessel degeneration in the retina. What roles might these other substances and 
mechanisms play? 
 In 1996 , King reported thathigh levels of glucose cause an increase in 
diacylglycerol(DAG), a phospholipid precursor that is synthesized from 
glyceraldehydes 3-phosphate and dihydroxyacetone phosphate. The latter two 
substances are generated in the E-M pathway from glucose. DAG stimulates the 
activity of protein kinase C (PKC), an enzyme that acts as a part of a hormone 
cascade system at cell surfaces . PKC, as part of its many physiological 
functions, increases both blood vessel permeability and the excessive synthesis 
of blood vessel membranes. One of the features of diabetic blood vessels is their 
50 
 
“leakiness” (permeability) and their thickening with the synthesis of basement 
membranes. In a more recent publication . Park et al(2000), indicate that PKC 
causes the induction of the synthesis of the protein endothelin-1(ET-1). This 
protein is responsible for increased blood vessel permeability as well as its 
thickening . similar effects may also be made through the activation of  mitogen 
activated protein (MAP) kinase, an enzyme that translocates into the nucleus of 
the cell and affects many different cell functions via phosphorylation (Lodish et 
al ,2000). 
Another effect of diabetes that arises from the Pandora’s box is the binding of 
glucose to proteins (glycation). In higher glucose concentrations , this occurs 
initially by what is known as the “Amadori rearrangement” of an initial Schiff 
base (aldimine) formation and is a ketimine. These protein-carbohydrate 
conjugates seem to occur in a number of extracellular proteins as well as the 
intracellular proteins of noninsulin dependent cells (Cohen, 1986). Such early 
stage complexes are exemplified by the existence of glycated hemoglobin 
(HbA1c) in the blood. HbA1c can actually be used to assay how well blood 
glucose control is being maintained in a diabetic (Wiliams, Pickup, 1999). 
Among those proteins known to be bound by glucose are collagen , crystallins, 
and enzymes such as NaK-ATPase, as well as hemoglobin. 
         Unfortunately, the initially formed protein-glucose ketimines may 
continue to react with time to form somewhat complex, permanent and 
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generally undefined, advanced glycation end-products (AGEs) as reported by 
Brownlee (1996). Among these AGEs, one has recently been described as an 
imidazole-crosslinked protein. AGEs produce a variety of effects including : (1) 
binding to receptors on vascular endothelial cells to produce a blockage in the 
vessel ; (2) a leakage of  the vessel itself; (3) vessel dilation; (4) vessel 
thickening (Rudnicka. Birch, 2000) and cell death by apoptosis (Kern et al, 
2000). 
        The process of oxidation has been proposed as an adjunct to the 
mechanistic formation of  AGEs from glucose and protein-glucose ketimines.  
Weiss et al (2000), describe how molecular oxygwn in conjunction with metal 
catalysts, may bring about the formation of  glyoxal and other intermediates 
prior to the crosslinking of proteins as AGEs. The mechanisms, in fact , remain 
somewhat speculative.   
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                                                         AIM OF STUDY 
 
(1) To analyze the correlation between Diabetic retinopathy status  and 
HbA1c values. 
(2) To study the relationship of  HDL2/HDL3 ratio with Diabetic 
Retinopathy status. 
 
METHOD OF STUDY 
 
MATERIALS AND METHODS 
100 Diabetic  patients  between the age group of  30 to 60 years of either sex 
were included in this study. Both type 1 and type 2 diabetic patients were 
included . 20 normal cases were kept as control. 40 cases were diabetics without 
retinopathy ,and 60 patients were diabetics with retinopathy. 
All the patients were subjected to detailed history and examination including 
detailed ocular examination, which included refraction ,intraocular pressure 
measurement, fundus examination, fundus fluorescein camera and angiography. 
Scott's classification (years) was used for the grading of diabetic retinopathy. 
Diabetes in all these patients was confirmed by estimating fasting and post-
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prandial blood sugar. The blood samples from over night fasting patients were 
obtained in EDTA vials (l mg/ ml of blood). Different fractions of lipoprotein 
were separated by using heparin manganese chloride and sodium dodecyl 
sulfate double precipitation technique. Total cholesterol and cholesterol content 
of lipoprotein fractions was estimated by the met by the method of Abell et al. 
Triglyceride was estimated by the technique of Van Handel and Zilversmit. 
 
 
SERUM  CHOLESTEROL AND  HDL SUBFRACTIONS ESTIMATION: 
It was done by Wybenga and Pileggi’s method using strangen reagent kit. A 
simple and precise method for measuring HDL-cholesterol subfractions is by a 
single precipitation followed by homogenous HDL-cholesterol assay. HDL 
consists of two major subfractions, HDL2 and HDL3. This describes a simple 
method for assaying HDL subspecies by combining a single precipitation with a 
direct high density lipoprotein-cholesterol (HDL-C) assay. A precipitation 
reagent (0.06 ml) containing 1,071 U/ml heparin, 500 mmol/l MnCl2) and 12 
mg/ml dextran sulfate was added to a serum (0.3 ml). The sample was incubated 
and centrifuged at 10,000 rpm for 10 min. HDL3-C was measured by a 
homogenous HDL-C assay in the supernatant, and HDL2-C was estimated by 
subtracting the HDL3-C from the direct HDL-C. The HDL3-C and HDL2-C 
values determined by the precipitation method were identical to those 
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determined by ultracentrifugation, and there were excellent correlations between 
the methods in the measurements of HDL3-C and HDL2-C (r = 0.933 and 
0.978, respectively; n = 102). The two methods also proved to be highly 
correlated in the measurement of apolipoprotein A-I and A-II in HDL 
subfractions. The HDL-C subfractions determined by ultracentrifugation were 
more closely associated with the homogenous HDL-C assay than with the total 
cholesterol assay, especially in the hypertriglyceridemic samples. 
SERUM TRIGLYCERIDE ESTIMATION: It is based on the following 
principle. N-heptane iso propanol mixture is used to separate out phospholipids 
from triglyceride,then  triglycerides are hydrolysed by saponification with 
potassium hydroxide followed by acidification. Glycerol liberated by meta 
periodate to formaldehyde which is measured  calorimetrically by reaction with 
acetyl acetone ammonia. 
ESTIMATION OF Hb1Ac : By columnar method . The caebohydrate moiety 
of glycosylated haemoglobin is converted into hydroxyl methyl furfural by 
heating with phosphoric acid.The hydroxymethyl  furfural  is then  incubated 
with Thiobarbituric acid to give a colored compound which is measured 
photometrically.  
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INSTRUMENTS USED 
1. Indirect and direct ophthalmoacope 
2. Haag Streit Slit lamp 
3. Goldmann’s applanation tonometer 
4. Goldmann’s 3 mirror lens 
5. Topcon fundus camera for fundus photography  
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                               ANALYSIS AND DISCUSSION 
 
In this analytical study, 100 patients  of diabetes mellitus who attended the 
diabetes clinic in the department of  diabetology in Government General 
Huspital , MMC, Chennai , from November 2006 to February 2007 were taken. 
The patients chosen were of the age group 30-60 years. . Both type 1 and type 2 
diabetic patients were included . 20 normal cases were kept as age matched 
control. Full detailed ophthalmic examination was carried out on all the patients. 
Blood analysis for lipid profile , which included HDL2 and HDL3 subfractions , 
Hb1Ac was also done meticulously using standard protocols for laboratory 
investigations. 
Incidence and Prevalence  
 Nearly 171 million people worldwide have diabetes. This figure is likely 
to double by 2030. India holds 31.7 million diabetic patients ranking first in the 
world. This number is projected to increase to 79.4 million by 2030.2 In India, 
prevalence of DR has been reported to range from 10.5% to 26.2% This study 
also reiterated the fact that the incidence of  diabetic retinopathy is more in 
males compared to females . In this study the  percentage of diabetic patients 
without retinopathy is 40 and those with retinopathy is 60. The further breakup 
of this 60 percent is NPDR 37% and PDR 23%. 
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SEX INCIDENCE 
1=MALE 
2=FEMALE 
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              CASES PROFILE 
1=DM WITH RETINOPATHY 
2=DM WITHOUT  
RETINOPATHY 
3=CONTROLS 
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Prevalence  
 
 
Sex incidence 
In this study , the percentage of males with diabetic retinopathy is 53.33 and 
females is 47. This finding correlated with the findings of earlier studies e.g. 
WEDSR, UKPDS, etc. that the incidence of diabetic retinopathy is more 
incident in males as compared to females. 
 
 
Out of 60 cases , 32 were  male and 28 cases were female.  
  
 
CONTROL CASES TAKEN FOR   STUDY 
20 age matched control cases were taken for this study. 10 were males and 10 
females. 
 
Diabetes mellitus No. of cases Percentage(%) 
DM without retinopathy 40 40 
NPDR 37 37 
PDR 23 23 
Sex No. of cases with diabetic 
retinopathy 
Percentage(%) 
Male 32 53.33 
Female 28 47 
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Analysis of Bio-chemical indices : 
HDL and HDL2/HDL3 Subfractions ratio: 
Study suggests that high HDL cholesterol may, independently of glycemic 
control, prevent the development of microvascular complications in  diabetes. 
These results could be related to antioxidant, antithrombotic, and anti-
inflammatory properties of HDL particles . Interestingly, structural 
modifications of HDL mediated by various mechanisms, including glycation, 
oxidation, and enzymatic degradation, may affect their functional and 
atheroprotective properties. This may suggest that not only quantity but also 
quality of HDL particles play a role in the damage of endothelium. 
HDL Values: 
 
The above values show that  HDL  Values are abnormal both in DM without 
and with retinopathy patients.It is 50.03 , 47.14 and 46.43 in DM without 
retinopathy, NPDR and PDR respectively. It also shows that lower values of 
HDL in patients with diabetic retinopathy shows a correlation with severity of 
diabetic retinopathy status . The ‘p’value  is <0.05 and  confidence interval is 
1.68, which shows that the data is statistically  significant. 
 DM without 
retinopathy 
NPDR PDR 
Mean 50.03 47.14 46.43 
Standard deviation 7.9 10.5 9.3 
P Value 
Confidence interval 
                            <0.05 
                              1.68  
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1=DM without retinopathy 
2= NPDR 
3= PDR 
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1= DM without retinopathy 
2= DM with retinopathy 
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Frequency distribution
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HDL2/HDL3 Subfractions ratio: 
HDL2/HDL3 RATIO 
 DM without retinopathy DM with retinopathy 
Mean 0.57 0.52 
Standard Deviation 0.14 0.18 
Confidence interval 
‘p’ value 
                                  0.031                                       
                             <0.05 Significant 
 
DM without retinopathy DM with retinopathy  
21 5 HDL2/HDL3 ratio N 
39 35 HDL2/HDL3 ratio    
 
ODD’S Ratio= 3.76 
Chi square test: 6.4                    ‘P’ value: <0.01 
The mean  HDL2/HDL3 ratio in diabetics without retinopathy is 0.57 and in with 
retinopathy it is 0.52.  This study shows a correlation with the decreased  
HDL2/HDL3 ratio with the severity of diabetic retinopathy status. This is 
statistically highly significant , ‘p’ value being <0.05. Moreover the odds ratio 
of correlation of HDL2/HDL3 ratio with  developing retinopathy in diabetic 
patients is shown to be 3.76 , which is a significant finding. The above data was 
statistically analysed by chi square test which shows that the above findings are 
not chance findings, ‘p’ value being <0.01.  
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HbA1c Values 
 DM without retinopathy DM with retinopathy 
Mean 8.615 8.313 
Standard Deviation 0.922524407 0.985396189 
Confidence interval 
‘p’ value 
                                    0.18                            
                             <0.05 Significant 
 
Chi  Square test:  4.1 
According to the above data, the mean HbA1c values in patients of DM without 
retinopathy is 8.615% and in patients of DM with retinopathy is 8.313%. The 
confidence interval is 0.18. We assessed the HbA1c values in order to assess  
the control of diabetic status. The slightly lower values of HbA1c in patients of 
DM with retinopathy could be explained by the fact that there could be a 
tendency towards more strict glycemic control in these subgroup of patients. As 
a corollary of the above findings , it can be postulated that the severity of 
diabetic retinopathy status bears a correlation with the level of glycosylated  
haemoglobin. 
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HbA1c Values 
1= DM without retinopathy 
2= DM with retinopathy 
 
69 
 
TGL  Values(mg/dl): 
 DM without 
retinopathy 
NPDR PDR 
Mean 76.77 84.48 92.69 
Standard 
deviation 
7 36 55 
P Value 
Confidence 
interval 
                            <0.05 
                              5.87 
 
The mean  serum triglycerides (P < 0.05)  were higher in subjects with 
DR compared with those without DR.  After adjusting for age, gender, 
duration of diabetes, total serum triglycerides were associated with DR  
After adjusting for HbA1c and body mass index, triglycerides maintained 
a significant association with DR . 
 There is a significant association of serum triglycerides with DR. The p 
Value is <0.05 and the confidence interval is 5.87. This finding also 
correlates with the earlier study done I,e. the Chennai Urban Rural 
Epidemiology Study (CURES) Eye Study—2. 
TC Values(mg/dl): 
 DM without 
retinopathy 
NPDR PDR 
Mean 133.82 148.77 151.33 
Standard deviation 13.76 37.17 29.51 
P Value 
Confidence interval 
                            <0.05 
                              4.50    
 
70 
 
The mean serum total cholesterol concentrations were higher in subjects 
with DR compared with those without DR. It is 133.82, 148.77, 151.33 
mg/dl in DM without retinopathy, NPDR and PDR respectively. The above 
finding is statistically significant because p value is <0.05 and the confidence 
interval is 4.50. 
 
LDL Values (mg/dl): 
 DM without 
retinopathy 
NPDR PDR 
Mean 68.43 83.82 84.66 
Standard deviation 13.80 28.17 25.08 
P Value 
Confidence interval 
                            <0.05 
                             4.38    
 
The above data clearly shows that there is a clear correlation between the level 
of LDL values and the severity of  Diabetic retinopathy. The mean LDL values 
are 68.43 ,83.82 , 84.66 mg/dl in patients of DM without retinopathy, NPDR 
and PDR respectively. The above finding is statistically significant because p 
value is <0.05 and the confidence interval is 4.38. 
 
This study revealed the following  relevant observations, which could be 
regarded as novel findings: 
1. Significantly lower values of HDL in patients with diabetic retinopathy 
shows a correlation with severity of diabetic retinopathy status . 
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1= DM without retinopathy 
2= NPDR 
3= PDR 
 
72 
 
 
1=DM without retinopathy 
2= NPDR 
3= PDR 
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\\\\
1=DM without retinopathy 
2= NPDR 
3= PDR 
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2. Study suggests that high HDL cholesterol may, independently of glycemic 
control, prevent the development of microvascular complications in  
diabetes. 
3. This study shows a correlation with the decreased  HDL2/HDL3 ratio with 
the severity of diabetic retinopathy status. 
4. This may suggest that not only quantity but also quality of HDL particles 
play a role in the damage of endothelium. 
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                                                  SUMMARY 
1. In this study 100 patients  of diabetes mellitus who attended the diabetes 
clinic in the department of  diabetology in Government General Hospital , 
MMC, Chennai , from November 2006 to February 2007 were taken. 
2. 40 cases were diabetics without retinopathy ,and 60 patients were 
diabetics with retinopathy. 
3. 20 normal cases were kept as age matched control. 
4. AGE GROUP 
The patients chosen were of the age group 30-60 years. 
5. SEX INCIDENCE 
In this study , the percentage of males with diabetic retinopathy is 53.33 
and females is 47. Males are affected more than the females. 
6. CLINICAL PROFILE 
40 cases were diabetics without retinopathy ,and 60 patients were 
diabetics with retinopathy. Of these 60 cases , 37 were of NPDR and 23 
were of PDR, i.e. 37% and 23% respectively. 
20 cases were taken from normal age matched population and were kept 
as controls. 
BIO-CHEMICAL INDICES STUDIED 
7. HDL 
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HDL values are abnormal both in DM without and with retinopathy 
patients. It is 50.03 , 47.14 and 46.43 in DM without retinopathy, NPDR 
and PDR respectively. 
It also shows that lower values of HDL in patients with diabetic retinopathy 
shows a correlation with severity of diabetic retinopathy status .  
8. HDL2/HDL3 Subfractions ratio 
The mean  HDL2/HDL3 ratio in diabetics without retinopathy is 0.57 and 
in with retinopathy it is 0.52.  This study shows a correlation with the 
decreased  HDL2/HDL3 ratio with the severity of diabetic retinopathy 
status. The odds ratio of correlation of HDL2/HDL3 ratio with  developing 
retinopathy in diabetic patients is shown to be 3.76 
Data was statistically analyzed by chi square test which shows that the 
above findings are not chance findings, ‘p’ value being <0.01.  
9. HbA1c Values 
The mean HbA1c values in patients of DM without retinopathy is 8.615% 
and in patients of DM with retinopathy is 8.313%. The confidence 
interval is 0.18. The slightly lower values of HbA1c in patients of DM 
with retinopathy could be explained by the fact that there could be a 
tendency towards more strict glycemic control in these subgroup of 
patients. 
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10. TGL  Values 
The mean  serum triglycerides (P < 0.05)  were higher in subjects with DR 
compared with those without DR.  It is 76.77 84.48 and 92.69 mg/dl in cases of 
DM without retinopathy, NPDR and PDR respectively. After adjusting for age, 
gender, duration of diabetes, total serum triglycerides were associated with DR  
After adjusting for HbA1c and body mass index, triglycerides maintained a 
significant association with DR . 
11. TC Values  
The mean serum total cholesterol concentrations were higher in subjects with 
DR compared with those without DR. It is 133.82, 148.77, 151.33 mg/dl in 
DM without retinopathy, NPDR and PDR respectively. There is a direct 
relation between the mean serum total cholesterol concentrations and the 
severity of diabetic retinopathy. It  is statistically significant because p value 
is <0.05. 
12. LDL Values 
There is a clear correlation between the level of LDL values and the 
severity of  Diabetic retinopathy. The mean LDL values are 68.43 ,83.82 , 
84.66 mg/dl in patients of DM without retinopathy, NPDR and PDR 
respectively. It is statistically significant because p value is <0.05. We 
can see that the severity of Diabetic retinopathy status is in direct 
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proportion with the level of LDL values in the different subcategories of 
diabetic retinopathy patients. 
To summarize ,our study suggests that high HDL cholesterol may, 
independently of glycemic control, prevent the development of 
microvascular complications in  diabetes. These results could be related 
to antioxidant, antithrombotic, and anti-inflammatory properties of HDL 
particles . Interestingly, structural modifications of HDL mediated by 
various mechanisms, including glycation, oxidation, and enzymatic 
degradation, may affect their functional and atheroprotective properties . 
This may suggest that not only quantity but also quality of HDL particles 
play a role in the damage of endothelium.  
We assessed the HbA1c values in order to assess  the control of diabetic 
status. As a corollary of the above findings , it can be postulated that the 
severity of diabetic retinopathy status bears a correlation with the level of 
glycosylated  haemoglobin. 
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                                                   CONCLUSIONS 
 
          From this study we were able to arrive at the following conclusions. 
1. Males are affected more than the females i.e. the incidence of diabetic 
retinopathy is more incident in males as compared to females. 
2. In India, prevalence of DR has been reported to range from 10.5% to 
26.2% 
3. In the clinical profile of the patients , NPDR was more prevalent than 
PDR. 
4. This study shows a correlation with the decreased  HDL2/HDL3 ratio with 
the severity of diabetic retinopathy status. The odds ratio of correlation of 
HDL2/HDL3 ratio with  developing retinopathy in diabetic patients is 
shown to be 3.76 
5. We assessed the HbA1c values in order to assess  the control of diabetic 
status. As a corollary of the above findings , it can be postulated that the 
severity of diabetic retinopathy status bears a correlation with the level of 
glycosylated  haemoglobin. 
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6. After adjusting for age, gender, duration of diabetes, total serum 
triglycerides were associated with DR in direct proportional relation.   
After adjusting for HbA1c and body mass index, triglycerides maintained 
a significant direct association with DR . 
7. There is a direct relation between the mean serum total cholesterol 
concentrations and the severity of diabetic retinopathy. 
8. The severity of Diabetic retinopathy status is in direct proportion with the 
level of LDL values in the different subcategories of diabetic retinopathy 
patients. 
9. Structural modifications of HDL mediated by various mechanisms, 
including glycation, oxidation, and enzymatic degradation, may affect 
their functional and atheroprotective properties. This may suggest that not 
only quantity but also quality of HDL particles play a role in the damage 
of endothelium. 
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                                               PROFORMA  
NAME: 
AGE: 
SEX:                                                            F/M 
OP/IP NO. 
OCCUPATION: 
AGE: 
PERSONAL HISTORY: SMOKING/ALCOHOLOIC 
                                          VEGETARIAN/NON-VEGETARIAN 
                      
AGE OF ONSET OF DIABETES: 
ANY OTHER DISORDER: 
DURATION OF DIABETES: 
CONTROL OF DIABETES:                      MEDICATIONS 
COMPLAINTS: 
OCULAR EXAMINATION:                    RE/LE 
VISUAL ACUITY 
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LIDS 
CONJ 
CORNEA 
ANTERIOR CHAMBER 
PUPIL 
IRIS 
LENS 
TENSION 
RETINOSCOPY 
SUBJECTIVE 
VISION CORRECTION 
FUNDUS 
A. DISTANT DIRECT 
B. DIRECT 
                       MEDIA/DISC/VESSELS 
SLIT LAMP EXAMINATION 
SYSTEMIC EXAMINATION 
INVESTIGATION 
BLOOD PRESSURE 
URINE:                                               ALBUMIN/SUGAR/DEPOSITS 
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TC/DC/ESR/HB 
FASTING BLOOD SUGAR 
GLYCOSYLATED HAEMOGLOBIN 
SERUM TRIGLYCERIDES 
SERUM CHOLESTEROL 
HDL 
HDL2 
HDL3 
FFA:           LEAKAGE 
                   AREAS OF CAPILLARY NON PERFUSION 
                   NEOVASCULARISATION 
                   IRMA 
DIAGNOSIS:                 
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NAME AGE/years SEX DURATION/ DIAGNOSISFBS(mg%) HbA1c(%) TGL (mg/dl TC(mg/dl) HDL(mg/dl)LDL(mg/dl) HDL3(mg/dHDL2(mg/d
Munusamy 32 M 5 DM 260 8.3 62 128 53.6 62 29.9 23.7 0.79
Veeran 31 M 6 DM 180.5 7.6 66.2 140 56.6 70.16 39.5 17.1 0.43
Subramani 40 M 4 DM 110 9.3 66 116 54.4 48.4 29.7 24.7 0.83
Joseph 32 M 3 DM 88.2 10.3 72.4 128 59.4 54.12 38.8 20.6 0.53
Balakondaiya 54 M 4 DM 112 7.6 68 122.6 48.5 60.5 29.6 18.9 0.64
Elumalai 44 M 5 DM 118 8 72 123.6 51.2 58 32.9 18.3 0.56
Chinnaya 43 M 4 DM 103 8.5 81.6 126 54.4 55.28 38.7 15.7 0.41
Yusuf 54 M 5 DM 72.8 10.2 81.6 140.1 51.4 72.38 34.2 17.2 0.5
Govindan 43 M 3 DM 166 9.5 84.8 144.6 43.2 84.44 29.5 13.7 0.46
Rajan 33 M 5 DM 133 7.9 81 141 53.2 71.6 38.12 15.1 0.4
Govindasamy 56 M 7 DM 129 8.9 68.8 128 48.6 65.64 29.7 18.9 0.64
Venkatesan 44 M 5 DM 246 8.9 77.4 148 48.7 83.82 32.7 16 0.49
Moorthy 54 M 6 DM 95 8.5 77.2 106 42.6 47.96 26.2 16.4 0.63
Thirumal 34 M 5 DM 161 6.9 71.7 121 48.9 57.76 32.7 16.2 0.5
Pichai 37 M 4 DM 309 8.1 83.2 129 45.6 66.76 31.4 14.2 0.45
Shiva 51 M 3 DM 127.8 8.9 67.4 138 51.8 72.72 34.2 17.6 0.51
Isac 54 M 5 DM 112.8 8.5 78.5 146 52.9 77.4 32.8 20.1 0.61
Perumal 56 M 3 DM 75 6.9 77.4 152 54.4 82.12 29.4 25 0.85
Rudran 43 M 6 DM 102 8.1 79.2 141 53.8 71.36 33.6 20.2 0.6
Selvam 32 M 3 DM 92 9.4 74.3 121.6 48.9 57.84 27.6 21.3 0.77
Kumar 47 M 5 DM 184.5 9.9 86 127.4 48.4 61.8 28.4 20 0.7
Velu 49 M 3 DM 223 11.2 74.4 108.7 52.8 41.02 32.1 20.7 0.64
Thirumoorthy 35 M 7 DM 173 7.8 68.4 126.4 48.9 63.82 30.4 18.5 0.61
Thirumalai 46 M 8 DM 182 7.7 77.4 141 53.6 71.92 28.9 24.7 0.85
Venkatasamy 56 M 8 DM 105 7.6 71.3 134.7 51.7 68.74 30.4 21.3 0.7
Raju 45 M 8 DM 164.4 9.3 84.4 142 46.3 78.82 28.6 17.7 0.62
Baskaran 34 M 8 DM 103 7.6 88.6 146 45.6 82.68 30.41 15.2 0.5
Chintamani 45 M 6 DM 166 9.5 66.2 128 52.2 62.56 39.4 12.8 0.32
Yellamalai 34 M 4 DM 121 8.2 68.8 112 46.8 51.44 28.5 18.3 0.64
Chinnatha 45 F 6 DM 211 8.3 95.6 124.4 50.6 54.68 35.9 14.7 0.41
Saroja 35 F 7 DM 131 8.4 84.4 126.8 52.4 57.52 32.6 19.8 0.61
Annatha 39 F 5 DM 94 8.3 72.5 146 54.4 77.1 30.1 24.3 0.81
Panchali 40 F 4 DM 133 8.4 88.6 160 42.6 99.68 28.5 14.1 0.49
Govindamma 57 F 7 DM 211 8.4 72.2 128.8 46.6 67.76 31.8 14.8 0.47
Dilli Bai 58 F 5 DM 131 8.3 76.2 142 49.2 77.56 29.7 19.5 0.66
Noorbibi 57 F 7 DM 94 8.6 86 148 48.5 82.3 27.8 20.7 0.74
Kamala 38 F 2 DM 133 8.3 80.9 157.3 46.7 94.42 30.1 16.6 0.55
Anandi 55 F 3 DM 211 9.4 88.6 147.3 42.6 86.98 32.6 10 0.31
Seetha 56 F 5 DM 154 9.6 76.7 109.7 46.7 47.66 33.1 13.6 0.41
Kanthammal 57 F 2 DM 74 9.5 73 156 52.6 88.8 34.8 17.8 0.51
Kamban 54 M 10 NPDR 156 7.7 120 168 53.6 90.4 36.9 16.7 0.45
Vellai 53 M 11 NPDR 160 8.4 91 159 46.6 94.2 28.6 18 0.63
Krishnasamy 56 M 11 NPDR 144 8.2 98 138 46.1 72.3 28.5 17.6 0.62
Rajendran 56 M 13 NPDR 130 8.3 138 151 45 79 31.6 13.4 0.42
Muhamed 51 M 12 NPDR 160 8.7 40 115 41 66 33.2 7.8 0.23
Babu 56 M 12 NPDR 144 8.5 50 114 42.6 59.2 26.7 15.9 0.6
Suresh 58 M 9 NPDR 162 8.3 80 147 53.6 77.4 32.4 21.2 0.65
Yesu 59 M 8 NPDR 154 8.2 141 110 30.7 51.1 20.4 10.3 0.5
Durairaj 54 M 12 NPDR 115 8.4 49 100 37.7 52.5 21.5 16.2 0.75
Basha 53 M 13 NPDR 123 8.3 44 126.4 32.1 85.5 20.4 11.7 0.57
Palani 56 M 12 NPDR 209 8.3 45 106 49.6 48 29.6 20 0.68
Swaminathan 57 M 11 NPDR 262 8.2 79 132 43.1 73.1 28 15.1 0.54
Muniyandi 56 M 11 NPDR 179 8.3 48 87 30.7 46.7 21 6.7 0.32
Nagaraj 55 M 10 NPDR 180 8.1 96 133 43.5 70.7 28.3 15.2 0.54
Andiappan 55 M 9 NPDR 150 8.6 98 138 36.1 72.4 24.9 11.2 0.45
Chuppan 50 M 12 NPDR 170 8.2 72 134.6 54.3 65.9 33.7 20.6 0.61
Vishnu 49 M 13 NPDR 132 8.6 177 239 37.8 165.8 27.6 10.2 0.37
Chittan 48 M 12 NPDR 159 8.2 82 136 44.3 75.3 28.3 16 0.57
Ganesan 47 M 12 NPDR 102 8.3 111 203 46.3 134.5 24.7 21.6 0.87
Velan 48 M 13 NPDR 146 8.6 65 108 38.1 56.9 21.8 16.3 0.75
Rama 49 F 12 NPDR 143 8.3 54 179 64 105 40.3 24 0.6
Susheela 55 F 11 NPDR 123 8.5 148 208 66.7 111.7 42.6 24.1 0.57
Karpagam 60 F 11 NPDR 112 8.3 68 164 70 80.4 46.7 23.3 0.5
Nalini 47 F 13 NPDR 76 10.9 147 246 55.3 161 34.1 21.2 0.62
Sheela 54 F 12 NPDR 92 9.4 98 143 35.5 88 21.4 14.1 0.66
Muniammal 56 F 11 NPDR 184 6.2 46 116 47.5 59.3 28.9 18.6 0.64
Rukmani 58 F 11 NPDR 223 7.6 76 145 41.5 88.3 24.3 17.2 0.71
Govindamma 48 F 11 NPDR 154 7.4 65.5 120.3 44.5 62.7 30.5 14 0.46
Selvi 58 F 11 NPDR 105 8.6 130 152 31.6 94.4 20 11.6 0.58
Nagammal 54 F 10 NPDR 106 8.2 42 180 67.1 104.5 38.7 28.4 0.73
Lalitha 54 F 11 NPDR 115 8.6 134.7 147 48.4 71.6 32.4 16 0.49
Sarada 56 F 12 NPDR 143 9.4 67 134 48.7 71.9 32.6 16.1 0.49
Kamakshi 54 F 12 NPDR 157 9.9 55.2 206 51.9 143 38.7 13.2 0.34
Sowmya 55 F 13 NPDR 167 7.4 44 120 49.7 61.5 29.8 19.9 0.67
Gowri 57 F 12 NPDR 134 7.6 62 160 53.2 94.4 30.4 22.8 0.75
Neela 53 F 11 NPDR 145 8.9 47 126 40.5 76.4 30.4 10.1 0.33
Rasathi 53 F 12 NPDR 165 10.8 120 168 52.5 91.5 40.8 11.7 0.29
Meenu 52 F 11 NPDR 167 7.1 82 194 70 83 36.7 33.3 0.91
Nithyanand 56 M 14 PDR 180 8.6 68 130 49.3 67.1 30.2 19.1 0.63
Mari 58 M 15 PDR 154 7.6 88 195 68.5 108 33.4 35.1 1.05
Nagaiyah 59 M 16 PDR 134 7.5 63 134 49.7 71.6 32.4 17.3 0.53
Mehamood 59 M 16 PDR 102 8.1 78 148 45.8 79.6 34.5 11.3 0.33
Gopal 58 M 17 PDR 104 8.4 148 167 58.3 79.1 31.8 26.5 0.83
Pichandi 57 M 18 PDR 166 6.9 64 140 51.4 75.8 34.7 16.7 0.48
Sethu 58 M 18 PDR 122 8.3 52 117 43.2 63.4 26.2 17 0.65
Kumar 60 M 16 PDR 211 8.7 49 114 42 62.2 26 16 0.62
Ganesan 58 M 17 PDR 131 9.4 284 149 45 49 27.9 17.1 0.61
Seethammal 56 M 15 PDR 94 8 88.8 214.4 41.6 154.6 28.9 12.7 0.44
Perumal 55 M 19 PDR 133 7.6 184.5 168.5 34.4 67.2 24.3 10.1 0.42
Andiappan 55 M 18 PDR 211 7.3 118 153 35.3 94 24.8 10.5 0.42
Ranga 58 M 18 PDR 154 7.1 128 208 42.3 140 36.9 5.4 0.15
Padmanaban 59 M 18 PDR 74 11.7 46 138 44.7 84 34.3 10.4 0.3
Dhanam 59 F 19 PDR 156 7.1 55 122 41.5 69.5 31.9 9.6 0.3
Ahalya 58 F 19 PDR 160 10.6 86 201 63.2 120.6 48.6 14.6 0.3
Nandini 57 F 17 PDR 115 7.4 63 143 46.9 83.5 38.6 8.3 0.22
Sheela 57 F 17 PDR 114 8.2 53 129 46.2 72.2 32.7 13.5 0.41
Seethammal 56 F 19 PDR 134 8.6 45 131 43.6 78.4 33.8 9.8 0.29
Kamalammal 56 F 20 PDR 179 7.2 77 141 40.8 84.8 31.7 9.1 0.29
Rajathi 59 F 16 PDR 82 7.4 114 158 43.5 91.7 30.5 13 0.43
Kasthuri 56 F 15 PDR 178 7.6 87 128 44.3 66.3 35.4 8.9 0.25
Ekambaram 44 M NA N 75 4.3 62 128 53.6 62 29.9 23.7 0.79
Venkatesh 55 M NA N 68.3 4.5 66.2 140 56.6 70.16 39.5 17.1 0.43
Velmurugan 34 M NA N 84.4 4.5 66 116 54.4 48.4 29.7 24.7 0.83
Thangavel 45 M NA N 66.4 4.5 72.4 128 59.4 54.12 38.8 20.6 0.53
Thirumalai 23 M NA N 72 4.6 68 122.6 48.5 60.5 29.6 18.9 0.64
Natesan 54 M NA N 69 4.6 72 123.6 51.2 58 32.9 18.3 0.56
Gyanavel 45 M NA N 71 4.7 81.6 126 54.4 55.28 38.7 15.7 0.41
Venkatasan 34 M NA N 72.4 4.7 81.6 140.1 51.4 72.38 34.2 17.2 0.5
Dakshinamoo 55 M NA N 80.9 4.6 84.8 144.6 43.2 84.44 29.5 13.7 0.46
54 M NA N 82 2 4 7 81 141 53 2 71 6 38 12 15 1 0 4
HDL2:HDL3 ratio
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Sheela 57 F 17 PDR 114 8.2 53 129
Seethammal 56 F 19 PDR 134 8.6 45 131
Kamalammal 56 F 20 PDR 179 7.2 77 141
Rajathi 59 F 16 PDR 82 7.4 114 158
Kasthuri 56 F 15 PDR 178 7.6 87 128
Ekambaram 44 M NA N 75 4.3 62 128
Venkatesh 55 M NA N 68.3 4.5 66.2 140
Velmurugan 34 M NA N 84.4 4.5 66 116
Thangavel 45 M NA N 66.4 4.5 72.4 128
Thirumalai 23 M NA N 72 4.6 68 122.6
Natesan 54 M NA N 69 4.6 72 123.6
Gyanavel 45 M NA N 71 4.7 81.6 126
Venkatasan 34 M NA N 72.4 4.7 81.6 140.1
Dakshinamoo 55 M NA N 80.9 4.6 84.8 144.6
Govinda 54 M NA N 82.2 4.7 81 141
Polachi 53 F NA N 64.4 4.4 68.8 128
Rani 56 F NA N 72.6 4.5 77.4 148
Shakuntala 33 F NA N 78 4.6 77.2 106
Indrani 32 F NA N 75 4.6 71.7 121
Subbammal 31 F NA N 68 4.8 83.2 129
Anusuya 56 F NA N 80 5 67.4 138
Kamakshi 42 F NA N 66 5.1 78.5 146
Sarada 43 F NA N 66 3.9 77.4 152
Rasathi 44 F NA N 67 3.7 79.2 141
Neela 43 F NA N 66 3.8 74.3 121.6
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                                 INDEX TO MASTER CHART 
 
OP/IP NO. = OUTPATIENT / INPATIENT NUMBER 
SEX:             F= FEMALE               M=MALE 
N= NORMAL 
DM= DIABETES MELLITUS 
NPDR= NONPROLIFERATIVE  
              DIABETIC RETINOPATHY 
PDR= PROLIFERATIVE DIABETIC RETINOPATHY 
FBS= FASTING BLOOD SUGAR 
HbA1c= GLYCOSYLATED HAEMOGLOBIN 
TGL= TOTAL TRIGLYCERIDES 
TC= TOTAL CHOLESTEROL 
HDL = HIGH DENSITY LIPOPROTEIN 
LDL = LOW DENSITY LIPOPROTEIN 
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                                                   ABBREVIATIONS 
 
DM: DIBETES MELLITUS 
DR: DIABETIC RETINOPATHY 
NPDR: NONPROLIFERATIVE  
            DIABETIC RETINOPATHY 
FBS:  FASTING BLOOD SUGAR 
HbA1c: GLYCOSYLATED HAEMOGLOBIN 
TGL:   TOTAL TRIGLYCERIDES 
TC :     TOTAL CHOLESTEROL 
HDL : HIGH DENSITY LIPOPROTEIN 
LDL :  LOW DENSITY LIPOPROTEIN 
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LIST OF SOME OPERATIONS PERFORMED DURING THE COURSE OF STUDY 
 
Sl. 
No. 
Name Age Sex OP/IP 
NO. 
Diagnosis Date of 
Surgery 
Type of Surgery 
1. Thangavel  60  M 68034 RE- MC, LE-
IMC 
23.08.06 RE-ECCEwith PCIOL 
2. Krishnammal 57 F 69034 LE- MC 20.09.06 LE-ECCEwith PCIOL 
3. Chinnaraj 65 M 406787 LE-MC 27.09.06 LE-ECCEwith PCIOL 
4. Vadivu 40 F 402253 RE-MC LE-
IMC 
11.10.06 RE-ECCEwithPCIOL 
5. Pathu 55 M 69887 LE-MC 18.10.06 LE-ECCEwithPCIOL 
6. Krishnan 54 M 407503 BE-IMC 25.10.06 BE-ECCEwithPCIOL 
7. Rani 59 F 16651 RE-MC LE-
IMC 
08.03.07 RE-ECCEwithPCIOL 
8. Lakshmi 65 F 15725 RE-HMC 
LE-IMC 
15.03.07 RE-ECCEwithPCIOL 
9. Ramu 66 M 15999 LE-IMC 22.03.07 LE-ECCEwithPCIOL 
10. Joseph 55 M 22658 LE- Sec. 
Phacolytic 
Glaucoma 
29.03.07 LE-Lens Removal 
11. Shanti 71 M 32544 LE-IMC 05.04.07 LE-ECCEwithPCIOL 
12. Subramani 70 M 28437 BE-IMC 19.04.07 RE-ECCEwithPCIOL 
13. Gajpati 60 M 412151 LE-IMC 21.04.07 LE-ECCEwithPCIOL 
14. Ahmad 55 M 412881 RE-MC 26.04.07 RE-ECCEwithPCIOL 
15. Pattamal 57 F 413106 BE-IMC 04.05.07 RE-ECCEwithPCIOL 
16. Loganathan 65 M 32288 LE-MC 07.05.07 LE-ECCEwithPCIOL 
17. Rajan 60 M 27159 RE-MC LE-
IMC 
11.05.07 RE-ECCEwithPCIOL 
18. Kausalya 50 F 31873 BE-MC 25.05.07 RE-SICSwithPCIOL 
19. Dhanalakshmi 50 F 31878 LE-PSC 28.05.07 LE-SICSwithPCIOL 
20. Periammal 70 F 33645 BE-MC 01.06.07 RE-ECCEwithPCIOL 
21. Kausalya 60 F 33702 RE-MC 04.06.07 RE-SICSwithPCIOL 
22. Pannaimmal 65 F 417201 BE-IMC 08.06.07 LE-SICS with PCIOL 
23. Parsaran 70 M 412714 RE-Chronic 
Dacryocystitis
24.09.07 RE- 
Dacryocystorhinostomy
24. Saroja 65 F 415022 LE-Pterygium 23.04.08 LE- Pterygium excision
25. Vridhammal 60 F 426519 RE-IMC 05.05.08 RE- SICS with PCIOL 
 
 
 
 
 
 
